Orris

Corpus cancer syndrome triad

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
The Corpus Cancer Syndrome Triad (also called the Endometrial/Uterine Corpus Cancer Triad) refers to the three conditions that classically co-occur in women with endometrioid endometrial carcinoma due to their shared underlying mechanism of unopposed estrogenic stimulation, primarily driven by obesity:

The Triad

ComponentMechanism
ObesityExcess adipose tissue converts androgens to estrone (peripheral aromatization), creating chronic unopposed estrogen stimulation of the endometrium
HypertensionCo-occurs with obesity via metabolic syndrome; also independently associated with endometrial cancer risk
Type 2 Diabetes MellitusInsulin resistance (also linked to obesity) promotes endometrial proliferation via insulin/IGF-1 signaling and elevated estrogen

Why These Three Co-occur

As described in Robbins & Cotran Pathologic Basis of Disease:
"The association with obesity underlies other conditions that commonly co-occur with endometrial carcinoma, particularly hypertension and type 2 diabetes."
Obesity is the central driver. Through:
  • Peripheral aromatization in fat tissue → excess estrone
  • Hyperinsulinemia / insulin resistance → reduced SHBG → more free estrogen
  • Metabolic syndrome → hypertension and T2DM as co-morbidities
This creates the classic phenotype: a postmenopausal, obese, hypertensive, diabetic woman presenting with postmenopausal bleeding — which is endometrial carcinoma until proven otherwise.

Additional Risk Factors (same pathway)

  • Nulliparity / infertility / anovulation
  • Unopposed exogenous estrogen therapy
  • Late menopause
  • Tamoxifen use
  • Polycystic ovarian syndrome (PCOS)

Clinical Relevance

  • These risk factors justify endometrial biopsy in any postmenopausal woman with uterine bleeding, even without all three components of the triad.
  • High-risk women (e.g., Lynch syndrome / HNPCC) warrant surveillance regardless of the metabolic triad.
  • The tumor type associated with this triad is Type I endometrial carcinoma (endometrioid, low grade, estrogen-dependent, good prognosis) — in contrast to Type II (serous, high-grade, estrogen-independent).
— Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 933; Berek & Novak's Gynecology, p. 2147
This is a shared conversation. Sign in to Orris to start your own chat.